Vaccines

European Medicines Agency Accepts Pfizer’s Marketing Authorization Application for Its Investigational 20-valent Pneumococcal Conjugate Vaccine for Adults 18 Years of Age or Older

Health, FDA, Other Health, General Health, Clinical trials, Pharmaceutical, Biotechnology, Vaccines, Health care, Medical specialties, Health, Pneumonia, Pneumococcal conjugate vaccine, Vaccination, Pfizer, Vaccine, Conjugate vaccine, Pneumococcal vaccine, Ruth Link-Gelles
Friday, February 26, 2021 - 11:45am

The epidemiology of pneumococcal serotypes causing disease has been changing due to the success of pneumococcal conjugate vaccines targeting pediatric and adult populations.

Key Points: 
  • The epidemiology of pneumococcal serotypes causing disease has been changing due to the success of pneumococcal conjugate vaccines targeting pediatric and adult populations.
  • In June 2020 Pfizer announced initiation of two Phase three trials for 20vPnC evaluating the safety and efficacy of the investigational vaccine in infants.
  • Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.
  • Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine.

Eurocine Vaccines confirms good immunological effect in preclinical study with the chlamydia vaccine candidate

Virology, Medical specialties, Vaccination, Vaccine, Medicine, Clinical medicine, Vaccines, Medical research
Friday, February 26, 2021 - 12:42am

Eurocine Vaccines AB ("Eurocine Vaccines") confirms good immunological effect in a preclinical animal study with its chlamydia vaccine candidate.

Key Points: 
  • Eurocine Vaccines AB ("Eurocine Vaccines") confirms good immunological effect in a preclinical animal study with its chlamydia vaccine candidate.
  • The good immunological effect of the tested vaccine surpasses, by a good margin, what in previous studies with our vaccine has provided protection in preclinical models.
  • STOCKHOLM, Sweden, Feb. 25, 2021 /PRNewswire/ -- In the current study, a chlamydia vaccine candidate, adapted to meet regulatory requirements, has been evaluated.
  • The study shows that Eurocine Vaccines' chlamydia vaccine candidate, after adaptation, remains highly immunogenic and focuses the immune response to the relevant parts of the chlamydia bacterium.

Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results

Medical specialties, Vaccines, Vaccination, Vaccine, Virology, Medicine, Health care, Medical research, Hypothetical technology
Thursday, February 25, 2021 - 9:01pm

Vaxart made this announcement as it provided financial results for the fourth quarter and full year endedDecember 31, 2020 and provided a corporate update.

Key Points: 
  • Vaxart made this announcement as it provided financial results for the fourth quarter and full year endedDecember 31, 2020 and provided a corporate update.
  • Vaxart is also advancing S-only vaccine candidates targeted specifically against variant strains, including one targeting the South African viral strain.
  • General and administrative expenses were $5.1 million for the fourth quarter of 2020 compared to $1.3 million for the fourth quarter of 2019.
  • There were no restructuring expenses for the fourth quarter of 2020 compared to $4.9 million for the fourth quarter of 2019.

Armanino Unveils Vaccine Registration & Administration System to Assist Government Agencies in Vaccine Rollout

Medical specialties, Biotechnology, Vaccination, Life sciences, Vaccine, Medicine, Vaccines, Medical research
Thursday, February 25, 2021 - 7:53pm

The latest addition in our library of solutions, our Vaccine Registration & Administration System is a mobile phone-based application that governmental entities can provide to their citizens to easily schedule their vaccination appointments.

Key Points: 
  • The latest addition in our library of solutions, our Vaccine Registration & Administration System is a mobile phone-based application that governmental entities can provide to their citizens to easily schedule their vaccination appointments.
  • Also, we have introduced our vaccination tracker that shows state-by-state performance on the distribution of vaccines.
  • Agencies register residents on a portal connected to the app, who are then contacted to schedule their first vaccine dose.
  • In addition to its core consulting and accounting practices, Armanino operates its division, AMF Media Group ( www.amfmediagroup.com ), a media and communications services agency.

WISeKey’s PKI technology allows the generation of Digital Vaccination Certificates (DVC) to be used as a proof of evidence for those who have received coronavirus vaccine

Cryptography, Key management, Public key infrastructure, Vaccines, Public-key cryptography, Passports, Vaccination, Public key certificate, International Certificate of Vaccination or Prophylaxis
Thursday, February 25, 2021 - 5:00pm

Digital Vaccine Certificates will facilitate the reopening of businesses and help societies to return to normal operating practices, but complexities on the different standards used to issue vaccination certificates make it very difficult for users to be able to prove that they have received the vaccine.

Key Points: 
  • Digital Vaccine Certificates will facilitate the reopening of businesses and help societies to return to normal operating practices, but complexities on the different standards used to issue vaccination certificates make it very difficult for users to be able to prove that they have received the vaccine.
  • DVC is a form of ID consisting of data related to the vaccine, such as date, type, and place of vaccination, and other relevant information.
  • Although the World Health Organization has been issuing paper "yellow cards" that act as certificates of vaccination for international travelers, these paper certificates could be subject to fraudulent activities.
  • The WISeKey RoT serves as a common trust anchor to ensure the integrity of online transactions among objects and between objects and people.

AHF Lauds News of 3 Million US COVID-19 Vaccines Daily by April

Pharmaceutical, AIDS, General Health, Health, FDA, Infectious diseases, Clinical trials, Other Health, Medicine, Medical specialties, Health, Medical research, AIDS Healthcare Foundation, Vaccine, AHF, COVID-19 vaccine, Food and Drug Administration, Vaccines
Wednesday, February 24, 2021 - 11:19pm

AIDS Healthcare Foundation ( AHF ) welcomed news that the U.S. will have 3 million vaccine doses per day available by April.

Key Points: 
  • AIDS Healthcare Foundation ( AHF ) welcomed news that the U.S. will have 3 million vaccine doses per day available by April.
  • Im confident in the rigorous approval process each of these vaccines have undergone at the FDA ensuring the vaccines are safe and effective.
  • Ryan White HIV Clinics, like the 68 healthcare centers AHF operates in 16 states, the District of Columbia and Puerto Rico, stand ready to offer our sites to administer COVID-19 vaccines.
  • To learn more about AHF, please visit our website: www.aidshealth.org , find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare .

New FDI World Dental Federation global survey reveals that two-thirds of countries are not allowing dentists to administer COVID-19 vaccines

Medical specialties, Medicine, Vaccines, Medical research, Health sciences, Vaccination, Virology, Influenza vaccine, Vaccine, COVID-19 vaccine, Dentistry
Wednesday, February 24, 2021 - 11:01pm

Fifty-seven member national dental associations, from across the globe, revealed that nearly two-thirds of countries had not granted permission to dentists to administer COVID-19 vaccines as part of national rollouts.

Key Points: 
  • Fifty-seven member national dental associations, from across the globe, revealed that nearly two-thirds of countries had not granted permission to dentists to administer COVID-19 vaccines as part of national rollouts.
  • In Europe, countries where dentists are not permitted to administer the vaccine include Switzerland, Portugal, Austria, Denmark, Slovakia, and Russia (see Table 1).
  • Significantly, some of these countries include those where dentists have not previously been allowed to administer vaccines, or at least the influenza vaccine.
  • Ahead of World Oral Health Day on March 20, FDI will release a new set of data around the caseload of COVID-19 infection amongst dentists around the world.

New FDI World Dental Federation global survey reveals that two-thirds of countries are not allowing dentists to administer COVID-19 vaccines

Medical specialties, Medicine, Vaccines, Medical research, Health sciences, Vaccination, Virology, Influenza vaccine, Vaccine, COVID-19 vaccine, Dentistry
Wednesday, February 24, 2021 - 11:01pm

Fifty-seven member national dental associations, from across the globe, revealed that nearly two-thirds of countries had not granted permission to dentists to administer COVID-19 vaccines as part of national rollouts.

Key Points: 
  • Fifty-seven member national dental associations, from across the globe, revealed that nearly two-thirds of countries had not granted permission to dentists to administer COVID-19 vaccines as part of national rollouts.
  • In Europe, countries where dentists are not permitted to administer the vaccine include Switzerland, Portugal, Austria, Denmark, Slovakia, and Russia (see Table 1).
  • Significantly, some of these countries include those where dentists have not previously been allowed to administer vaccines, or at least the influenza vaccine.
  • Ahead of World Oral Health Day on March 20, FDI will release a new set of data around the caseload of COVID-19 infection amongst dentists around the world.

Vaxart to Provide 2021 Business Outlook on Tuesday, March 2, 2021

Vaccines, Medical specialties, Life sciences, Medicine, Medical research, Vaccination, Virology, Vaxart, Vaccine, Adenoviridae, COVID-19 vaccine
Wednesday, February 24, 2021 - 9:01pm

Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform.

Key Points: 
  • Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform.
  • Vaxart vaccines are designed to be administered using tablets that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury.
  • Vaxart has believes that its proprietary tablet vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications.
  • Vaxart has filed broad domestic and international patents covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.

Survey Finds Only 11 Percent of People Living with Chronic Health Conditions Have Been Contacted by their Doctor about the COVID-19 Vaccine

Medical specialties, Vaccination, Vaccine, Virology, Vaccines, Medicine, Clinical medicine, Influenza vaccines, Vaccine hesitancy
Wednesday, February 24, 2021 - 6:00pm

"Until they hear a specialist in their disease address five of the biggest concerns they have, they are unlikely to get vaccinated soon."

Key Points: 
  • "Until they hear a specialist in their disease address five of the biggest concerns they have, they are unlikely to get vaccinated soon."
  • Top questions and concerns about the vaccine among those surveyed include:
    Will the vaccine interfere with my medications?
  • (39%)
    "Nearly 1 in 2 people living with a chronic health condition is worried that the vaccine will interfere with their current treatment or exacerbate the symptoms of their underlying disease," said Peacock.
  • MyHealthTeams creates social networks that provide support and information for people living with a chronic health condition.